Spotify's acquisition last week of the music licensing start-up Loudr helps the streaming service to better manage its costs so that it can focus on attracting new subscribers for its premium service, said a digital media investment banker who helped Loudr close the deal. Loudr's services are intended to make it easier for content creators and digital music services to identify, track, and pay royalties to music publishers more efficiently. Royalties are, of course, part of Spotify's recurring costs. "It makes sense for Spotify, which is the largest music streaming service in terms of paid users, to take control of this important piece," said Sun Jen Yung, a partner and the head of digital media at Nfluence Partners. Loudr makes the complex process of paying royalties easier through automation, she said Wednesday in an interview on Cheddar. This week, Spotify announced it will update its mobile app soon in an effort to make it easier to use. "To the extent that they can attract more users, that can hopefully help them upgrade to a premium service," said Yung. For full interview, [click here](https://cheddar.com/videos/inside-spotifys-acquisition-of-loudr).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More